Novo Nordisk and Arogga Partner to Expand Digital Diabetes Care
To make diabetes care more accessible and convenient through digital channels, Novo Nordisk Pharma Pvt. Limited has signed a memorandum of understanding (MoU) with Arogga Limited. The partnership is also expected to make it easier for patients to access genuine Novo Nordisk products through digital platforms.
Under the agreement, Arogga Limited will provide online ordering and delivery services for Novo Nordisk products within Dhaka city. The delivery process will strictly comply with cold-chain standards to ensure product quality. In addition, QR code–enabled usage guidelines will be provided to help patients use the products correctly. By combining technology with accessibility, the initiative aims to ensure product integrity while setting a new benchmark for patient-centric innovation in the country.
The signing ceremony was attended by Dr Mohammad Riad Mamun Pradhani, Managing Director of Novo Nordisk Pharma Pvt. Limited, and Dr Mahbubur Rahman, Director of the Clinical, Medical and Regulatory Division, on behalf of Novo Nordisk. Representing Arogga Limited were Rozina Majumdar, Co-founder and Chief Executive Officer, and Yawer Mehboob, Co-founder and Chief Strategy Officer.
